- Midazolam 20mg/5ml oral suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Midazolam 20mg/5ml oral suspension | Start Date 09-01-2008 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 3 (CD No Register Exempt Safe Custody)
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N05CD08
- BNF Codes
-
- BNF code 04080200
Code | Start Date | End Date |
---|---|---|
13009811000001106 | 09-01-2008 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Midazolam maleate | Based on Base Substance | Midazolam | 4 mg | 1 ml |
Name
Midazolam maleate
Basis of strength description
Based on Base Substance
BOSS
Midazolam
Strength and UOM (Nmr)
4
Strength and UOM (Dmr)
1
Parent Products
-
VTMMidazolam
-
VMP(Current) Midazolam 20mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml |